INOZYME PHARMA, INC. Increase (Decrease) in Accrued Liabilities
INOZYME PHARMA, INC. reported Increase (Decrease) in Accrued Liabilities of -$3.21 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2025-05-14
- INOZYME PHARMA, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-03-31 was -$3.21M.
- INOZYME PHARMA, INC. increase (decrease) in accrued liabilities for the quarter ending 2024-12-31 was $4.38M, a 35.79% increase year-over-year.
- INOZYME PHARMA, INC. increase (decrease) in accrued liabilities for the quarter ending 2024-09-30 was $516.00K, a 189.89% increase year-over-year.
- INOZYME PHARMA, INC. increase (decrease) in accrued liabilities for the quarter ending 2024-06-30 was $1.75M.
- INOZYME PHARMA, INC. increase (decrease) in accrued liabilities for fiscal 2024 was $3.34M, a 166.37% increase from fiscal 2023.
- INOZYME PHARMA, INC. increase (decrease) in accrued liabilities for fiscal 2023 was $1.25M, a 56.07% decline from fiscal 2022.
- INOZYME PHARMA, INC. increase (decrease) in accrued liabilities for fiscal 2022 was $2.86M, a 52.70% increase from fiscal 2021.
- INOZYME PHARMA, INC. increase (decrease) in accrued liabilities for fiscal 2021 was $1.87M, a 52.37% decline from fiscal 2020.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2025-03-31 | -$3.21M 10-Q · filed 2025-05-14 | $1.17M derived: sum of 2 quarters · filed 2025-05-14 | $1.69M derived: sum of 3 quarters · filed 2025-05-14 | $3.44M derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-12-31 | $4.38M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $4.90M derived: sum of 2 quarters · filed 2025-03-10 | $6.65M derived: sum of 3 quarters · filed 2025-03-10 | $3.34M 10-K · filed 2025-03-10 |
| 2024-09-30 | $516.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $2.27M derived: sum of 2 quarters · filed 2024-11-05 | -$1.04M 10-Q · filed 2024-11-05 | $2.19M derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-06-30 | $1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$1.55M 10-Q · filed 2024-08-06 | $1.67M derived: sum of 3 quarters · filed 2025-05-14 | $1.85M derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-03-31 | -$3.30M 10-Q · filed 2025-05-14 | -$77.00K derived: sum of 2 quarters · filed 2025-05-14 | $101.00K derived: sum of 3 quarters · filed 2025-05-14 | -$626.00K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $3.23M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $3.40M derived: sum of 2 quarters · filed 2025-03-10 | $2.68M derived: sum of 3 quarters · filed 2025-03-10 | $1.25M 10-K · filed 2025-03-10 |
| 2023-09-30 | $178.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$549.00K derived: sum of 2 quarters · filed 2024-11-05 | -$1.97M 10-Q · filed 2024-11-05 | -$1.55M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | -$727.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$2.15M 10-Q · filed 2024-08-06 | -$1.73M derived: sum of 3 quarters · filed 2024-08-06 | $728.00K derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | -$1.42M 10-Q · filed 2024-05-07 | -$1.00M derived: sum of 2 quarters · filed 2024-05-07 | $1.46M derived: sum of 3 quarters · filed 2024-05-07 | $626.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $422.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $2.88M derived: sum of 2 quarters · filed 2024-03-12 | $2.05M derived: sum of 3 quarters · filed 2024-03-12 | $2.86M 10-K · filed 2024-03-12 |
| 2022-09-30 | $2.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $1.63M derived: sum of 2 quarters · filed 2023-11-07 | $2.44M 10-Q · filed 2023-11-07 | $3.36M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$829.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$21.00K 10-Q · filed 2023-08-08 | $908.00K derived: sum of 3 quarters · filed 2023-08-08 | $2.99M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $808.00K 10-Q · filed 2023-05-09 | $1.74M derived: sum of 2 quarters · filed 2023-05-09 | $3.82M derived: sum of 3 quarters · filed 2023-05-09 | $4.95M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $929.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $3.01M derived: sum of 2 quarters · filed 2023-03-22 | $4.14M derived: sum of 3 quarters · filed 2023-03-22 | $1.87M 10-K · filed 2023-03-22 |
| 2021-09-30 | $2.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $3.21M derived: sum of 2 quarters · filed 2022-11-10 | $942.00K 10-Q · filed 2022-11-10 | $1.29M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$1.14M 10-Q · filed 2022-08-15 | -$796.00K derived: sum of 3 quarters · filed 2022-08-15 | $681.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | -$2.27M 10-Q · filed 2022-05-10 | -$1.93M derived: sum of 2 quarters · filed 2022-05-10 | -$449.00K derived: sum of 3 quarters · filed 2022-05-10 | $842.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $346.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $1.82M derived: sum of 2 quarters · filed 2022-03-15 | $3.11M derived: sum of 3 quarters · filed 2022-03-15 | $3.93M 10-K · filed 2022-03-15 |
| 2020-09-30 | $1.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $2.77M derived: sum of 2 quarters · filed 2021-11-09 | $3.58M 10-Q · filed 2021-11-09 | $4.28M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $2.10M 10-Q · filed 2021-08-11 | $2.80M derived: sum of 3 quarters · filed 2021-08-11 | $3.43M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $814.00K 10-Q · filed 2021-05-12 | $1.51M derived: sum of 2 quarters · filed 2021-05-12 | $2.14M derived: sum of 3 quarters · filed 2021-05-12 | |
| 2019-12-31 | $694.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $1.33M derived: sum of 2 quarters · filed 2021-03-25 | $930.00K 10-K · filed 2021-03-25 | |
| 2019-09-30 | $632.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $236.00K 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | -$396.00K 10-Q · filed 2020-09-03 |